Dr Colin Story
InvestorAdvisory Board Member at UK Innovation & Science Seed Fund
About
Colin Story joined UKI2S as an advisory board member in November 2023 and has a background in business development within engineering biology organisations. He started his career at GE Healthcare in product development and project management before moving to Isis Innovation, where he built a business development team managing over 200 medical science innovations from Oxford University, and later served as Operations Director at OrganOx. He co-founded OxSonics in 2013 and was its CEO from 2014 to 2022, raising £25m across three rounds.
Invests in
BiotechMedical Devices
Investments
Board seats
BetaGlue Technologies SpAHox Therapeutics Limited
Per the firm's website.
Colleagues at UK Innovation & Science Seed Fund
Alexander Leigh
Investment Director Defence & Security at UK Innovation & Science Seed Fund
Alison Campbell
Investor at UK Innovation & Science Seed Fund
Andrew Muir
Investment Director at UK Innovation & Science Seed Fund
Betty Bonnardel
Investor at UK Innovation & Science Seed Fund
Dr Peter Hamley
Investor at UK Innovation & Science Seed Fund
Eddie Alleyn
Investor at UK Innovation & Science Seed Fund
Hassan Mahmudul
Investment Manager at UK Innovation & Science Seed Fund
John Patterson
Investor at UK Innovation & Science Seed Fund








